Cargando…

ODP204 Hemochromatosis and endocrine dysfunctions – a case report

INTRODUCTION: Hemochromatosis is characterized by iron overload that can lead to deposit in various organs such as liver, pancreas, pituitary gland, resulting in endocrine dysfunction. Pancreatic iron deposition can lead to diabetes mellitus, and pituitary deposition to hypopituitarism. Liver is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Davide, Gonçalves, Juliana, Neves, Celestino, Neves, João Sérgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628614/
http://dx.doi.org/10.1210/jendso/bvac150.656
_version_ 1784823227303854080
author Carvalho, Davide
Gonçalves, Juliana
Neves, Celestino
Neves, João Sérgio
author_facet Carvalho, Davide
Gonçalves, Juliana
Neves, Celestino
Neves, João Sérgio
author_sort Carvalho, Davide
collection PubMed
description INTRODUCTION: Hemochromatosis is characterized by iron overload that can lead to deposit in various organs such as liver, pancreas, pituitary gland, resulting in endocrine dysfunction. Pancreatic iron deposition can lead to diabetes mellitus, and pituitary deposition to hypopituitarism. Liver is the principal affected organ and that can lead to various complications like hepatomegaly, cirrhosis, and hepatocellular carcinoma. CASE REPORT: A 67 years-old caucasian man was diagnosed with hemochromatosis at 30 years old. At that time, undergoing periodic phlebotomies. After 3 years, he was diagnosed with diabetes mellitus and started basal-bolus insulin therapy. In 2006 he submitted to laser photocoagulation due developed to non-proliferative retinopathy. At the present presents microalbuminuria with urine albumin to creatinine ratio of 65. 0 mg/g. The pituitary function reveals hypogonadotropic hypogonadism with no other axis affected. He was medicated with 250 mg enanthate testosterone injection monthly. He also developed cirrhosis Child-Pugh A and in 2018 was diagnosed with multicentric hepatocarcinoma. He was submitted at radioembolization of hepatic lesions in 2019 and in 2021. Due to disease progression, he started treatment with tyrosine kinase inhibitors (sorafenib 800 mg daily) in 2021. Recently, atrial fibrillation was diagnosed, and he started anticoagulation with apixaban 5. 0 mg twice a day. CONCLUSION: Secondary causes of endocrinopathies such as diabetes mellitus and hypogonadism are relatively infrequent. This case alerts to diseases associated with hemochromatosis at long term, such as diabetes mellitus, hypogonadism, cirrhosis and hepatocarcinoma. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9628614
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96286142022-11-04 ODP204 Hemochromatosis and endocrine dysfunctions – a case report Carvalho, Davide Gonçalves, Juliana Neves, Celestino Neves, João Sérgio J Endocr Soc Diabetes & Glucose Metabolism INTRODUCTION: Hemochromatosis is characterized by iron overload that can lead to deposit in various organs such as liver, pancreas, pituitary gland, resulting in endocrine dysfunction. Pancreatic iron deposition can lead to diabetes mellitus, and pituitary deposition to hypopituitarism. Liver is the principal affected organ and that can lead to various complications like hepatomegaly, cirrhosis, and hepatocellular carcinoma. CASE REPORT: A 67 years-old caucasian man was diagnosed with hemochromatosis at 30 years old. At that time, undergoing periodic phlebotomies. After 3 years, he was diagnosed with diabetes mellitus and started basal-bolus insulin therapy. In 2006 he submitted to laser photocoagulation due developed to non-proliferative retinopathy. At the present presents microalbuminuria with urine albumin to creatinine ratio of 65. 0 mg/g. The pituitary function reveals hypogonadotropic hypogonadism with no other axis affected. He was medicated with 250 mg enanthate testosterone injection monthly. He also developed cirrhosis Child-Pugh A and in 2018 was diagnosed with multicentric hepatocarcinoma. He was submitted at radioembolization of hepatic lesions in 2019 and in 2021. Due to disease progression, he started treatment with tyrosine kinase inhibitors (sorafenib 800 mg daily) in 2021. Recently, atrial fibrillation was diagnosed, and he started anticoagulation with apixaban 5. 0 mg twice a day. CONCLUSION: Secondary causes of endocrinopathies such as diabetes mellitus and hypogonadism are relatively infrequent. This case alerts to diseases associated with hemochromatosis at long term, such as diabetes mellitus, hypogonadism, cirrhosis and hepatocarcinoma. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9628614/ http://dx.doi.org/10.1210/jendso/bvac150.656 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes & Glucose Metabolism
Carvalho, Davide
Gonçalves, Juliana
Neves, Celestino
Neves, João Sérgio
ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title_full ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title_fullStr ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title_full_unstemmed ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title_short ODP204 Hemochromatosis and endocrine dysfunctions – a case report
title_sort odp204 hemochromatosis and endocrine dysfunctions – a case report
topic Diabetes & Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628614/
http://dx.doi.org/10.1210/jendso/bvac150.656
work_keys_str_mv AT carvalhodavide odp204hemochromatosisandendocrinedysfunctionsacasereport
AT goncalvesjuliana odp204hemochromatosisandendocrinedysfunctionsacasereport
AT nevescelestino odp204hemochromatosisandendocrinedysfunctionsacasereport
AT nevesjoaosergio odp204hemochromatosisandendocrinedysfunctionsacasereport